-
Are you counting the days like we do? If so, you already know there's just ONE MONTH until
#FOBUSA2020.
- 350 speakers
- 1,000 #antibody,#immunotherapy and#biosimilars experts
- 3 conferences during 3 jam-packed days
Join us in San Diego: https://buff.ly/38W2oQd pic.twitter.com/TtTdWfkIo4 -
#BAPS_2020#April_21_22_2020#Paris#microbial_Biotechnology#Biosensors#Biosimilars#Agriculture#Marine#Food#Soil_Fertility#Registrations_opens Submit your abstract and hold your slot in this conference Call for#Abstracts Email: plantscience@biotechnologyconferences.orgpic.twitter.com/PoBRocxXw6 -
Just a month until North America's most exciting event in
#biologics,#antibody,#immunotherapy and#biosimilars opens its doors
Our flash sale means you save $250 before midnight. 
Join 350 Speakers & 1,000 #lifescience experts at#FOBUSA2020. https://buff.ly/38W2oQd pic.twitter.com/pgRZ8QkAcx -
Watch the
#Top 5 reasons to choose evitria AG for your outsourcing needs!! For more details visit: https://lnkd.in/d5qg2Jg Write us at: info@worldbigroup.com or Visit: https://worldbigroup.com/#drug#drugdiscovery#biomarkers#biosimilars#science#informatics#oncologypic.twitter.com/mFw03oxm2r -
Does
@kiranshaw of@Bioconlimited think that the company is getting into a phase where various catalysts are getting unfolded for the#biosimilars business after a long wait? Tune in for an excerpt from the interview on ‘The Market’ pic.twitter.com/dPaYam3KRp -
There is not a one-size-fits-all solution for patients when it comes to treating
#cancer. But#biosimilars are a potential option that may help increase patient access to treatment. Learn more about the value of#biosimilars in#cancer care#ASH19 https://on.pfizer.com/2qr0Dda pic.twitter.com/TfJfQemTFQ -
What do you know about
#biosimilars? Join us for the ride to learn about these important treatment options and what they can potentially offer for patients with#bloodcancer#ASH19 https://on.pfizer.com/2DQyOhp pic.twitter.com/da6J9jUk1U -
Learn more about
#direct &#indirect#costs of#IBD on the episode with CEO of@getgutsycanada@MinaMawani & Dr. Targownik@UofT_GI_Head#Forcedswitching#biologics#biosimilars#Patientdoctorchoice@PlayerFM - https://bit.ly/2NSLxVN@iTunes - https://apple.co/34tZmAnwnik pic.twitter.com/W8wPN8Hr0f -
.
@Vohra_Umang shares@Cipla_Global#Q1FY20 Highlights - US Specialty portfolio growth gains momentum. We continue to expand our global presence through strategic partnerships -#biosimilars in emerging markets and respiratory foray in China. https://youtu.be/l70QLGqpo2Y -
#DYK that#biosimilars are cultured in living cells? No two batches are exactly alike so rigorous quality controls are critical. pic.twitter.com/LwA2qVyKVM -
We’re proud to be the industry leader with seven
@US_FDA approved#biosimilars, though more must be done to ensure#patients are able to access these important treatment options. Learn more: https://on.pfizer.com/2LCGGsN pic.twitter.com/YXtZVkcDvk -
#DYK Biologics and#biosimilars are produced using a sophisticated, highly technical, multistep process pic.twitter.com/kfCX7GTdph -
#BC is leading the country by promoting greater use of#biosimilars, a necessary step to boost existing coverage for people living with health conditions like#arthritis. This will also help fund new drugs well into the future. https://youtu.be/6JDazrHEEf0@ArthritisSoc -
What are the benefits of oncology
#biosimilars? Discover the potential of these important new treatment options: https://on.pfizer.com/2xibshJ pic.twitter.com/3TNgvcM65F -
“I certainly think for patients with
#arthritis today is a great day in British Columbia,” said Dr.@jesdaile of our announcement expanding the use of#biosimilars. This will create new drug listings and boost existing coverage. https://youtu.be/iBH87OF4nSs@Arthritis_ARC -
#Biosimilars represent opportunities to create more affordable, lifesaving treatments for cancer patients like Gail, our wonderful@ACSCANIowa volunteer. Increasing access to biosimilars will lower costs & make new discoveries more available for patients.https://bit.ly/2Rot8kR -
Interview to @isaamat and Dr Andreu Soldevila of Syna Therapeutics, a joint venture of Reig Jofre and@leanbiopro that develops#biosimilars, as new member of@CataloniaBioHT
https://youtu.be/c4ia_Rpn2no -
There could be €100M extra health funding every year if the Govt let the HSE use
#BioSimilarsNow. Spokesperson on Primary Care and Community Health Services, as well as practicing pharmacist,@BrassilJohnTD explains how.#SpinrazaNow#Biosimilars#DrugPricingpic.twitter.com/K7bw1R6bJX -
Looking forward to seeing you at the
#GRxBiosims Conference. More on what you can expect at this important industry event: http://bit.ly/2PojugR#biosimilars@biosimscouncil@accessiblemedspic.twitter.com/OLl9YDWqPe
-
NEW VIDEO: Watch CDER’s Director of the Office of Biotechnology Products explain the data requirements for demonstrating analytical similarity of
#biosimilars to reference products. https://go.usa.gov/xQyRZ https://youtu.be/mGKcSFsyrLg
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.